TickerFactsScreenerDevelopers

Can-Fite BioPharma Ltd. (CANF) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $8.12M2017: $3.50M2018: $3.62M2019: $2.70M2020: $8.27M2021: $4.39M2022: $2.98M2023: $4.28M2024: $4.83M2025: $5.53M$5.53M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$5.53M+14.6%
2024$4.83M+12.8%
2023$4.28M+43.7%
2022$2.98M-32.2%
2021$4.39M-46.9%
2020$8.27M+206.6%
2019$2.70M-25.4%
2018$3.62M+3.1%
2017$3.50M-56.8%
2016$8.12M—